Testing for antiphospholipid antibodies: Problems and solutions

Clinical Obstetrics and Gynecology

Volumn 44, Issue 1, 2001, Pages 48-57

  Pierangeli, Silvia S ^a   Gharavi, Azzudin E ^a   Harris, E Nigel ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; REVIEW; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0035135986     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200103000-00007     Document Type: Review

References (56)

1. Antiphospholipid syndrome
2. Syndrome of the black swan
3. 2glycoprotein 1?
4. Anticardiolipin (ACA) antibodies directed not to cardiolipin but to a plasma protein cofactor
5. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor
6. The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus
7. Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders
8. Prevalence, significance, and specificity of antibodies to phospholipids in Q fever
9. Anticardiolipin antibodies associated with HTLV-III infection
10. Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities
11. Thrombosis, recurrent fetal loss, and thrombocytopenia predictive value of the anti-cardiolipin test
12. Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held April 4 1986
13. The second international anticardiolipin standardization workshop/the Kingston Antiphospholipid Antibody study (KAPS) group
14. Anticardiolipin wet workshop report: Vth International Symposium on antiphospholipid antibodies
15. Report of an anticardiolipin wet workshop during the VIIth International Symposium on antiphospholipid antibodies
16. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant
17. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis
18. Anticardiolipin antibody isotype distribution and phospholipid specificity
19. Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin
20. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol, and phosphatidylserine in systemic lupus erythematosus: Prospective analysis of a series of 92 patients
21. IgA anticardiolipin antibodies: Relation with other antiphospholipid antibodies and clinical significance
22. Significance of IgA antiphospholipid antibodies
23. Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid syndrome
24. Multicenter evaluation of nine commercial kits for the quantitation or anticardiolipin antibodies
25. Interlaboratory variation in antiphospholipid antibody testing
26. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus
27. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity
28. Hemolytic anemia related to an autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes
29. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients
30. Binding specificity of lupus anticoagulants and anticardiolipin antibodies
31. Induction of antiphospholipid autoantibody during cytomegalovirus infection
32. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus
33. High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation
34. A more specific ELISA assay for the detection of antiphospholipid
35. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with a variety of connective tissue diseases
36. 2glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface
37. 2glycoprotein 1 in the absence of phospholipid: Importance of antigen density and bivalent binding
38. 2glycoprotein 1 antibodies: A marker of antiphospholipid syndrome?
39. Diagnosis of the antiphospholipid syndrome: A proposal for use of laboratory tests
40. Anti-beta glycoprotein 1 antibodies: Detection and association with thrombosis
41. 2-glycoprotein 1 antibodies and lupus anticoagulant in patients with recurrent pregnancy loss, prevalence and clinical significance
42. 2-glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women
43. 2glycoprotein 1 in autoantibody-mediated pregnancy loss
44. 2glycoprotein 1 as an antigen
45. 2glycoprotein 1 in patients with antiphospholipid syndrome
46. 2glycoprotein I, a specific marker for antiphospholipid syndrome
47. 2glycoprotein 1 antibodies
48. 2glycoprotein 1 in HIV-seropositive patients: Relationship with endothelial activation and antimalonic dialdehyde antibodies
49. 2glycoprotein I and anti-prothombin antibodies in chronic hepatitis C
50. 2glycoprotein I contribute to a better characterization of the antiphospholipid syndrome
51. 2glycoprotein I in systemic lupus erythematosus and primary antiphospholipid syndrome: Clinical correlations in comparison with other antibody tests
52. 2glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis
53. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin
54. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: An explanation for their pathogenic mechanism?
55. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody
56. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop